Business Context and Reporting Period
This Form 8-K is a current report filed by Mast Therapeutics, Inc. (not Savara Inc.) on August 6, 2013. The report discloses a corporate governance event regarding the departure of a board member.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and contains no financial data.
Material Changes
Departure of Director: On August 6, 2013, Ted W. Love resigned from the Company's board of directors and all board committees. The resignation became effective on August 7, 2013.
- Reason: Dr. Love cited other commitments as the reason for his departure.
- Disagreement: The filing explicitly states the resignation was not due to any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the standard disclosure of the director's resignation.
Key Facts for Investor Verification
- Verify the current composition of the Board of Directors following Dr. Love's resignation.
- Confirm whether the Company has appointed a replacement director to fill the vacancy.
- Note that the registrant name in the filing is Mast Therapeutics, Inc., which may differ from the user's requested company name (Savara Inc.).